Hepatitis D is a liver inflammatory disease caused by hepatitis delta virus. It is not transmitted apart from hepatitis B because of its inability to penetrate into liver cells. This is why the patients diagnosed with hepatitis D always have hepatitis B. Hepatitis D is dangerous because it complicates the treatment of hepatitis B, which is not easy to be treated as such.
Symptoms and diagnostics
Symptoms of the viruses B and D are very much alike: they include fever, nausea, weakness, drowsiness, loss of appetite, liver pain. Such state of health occurs in about 50 %. Joint pain manifests in about 30 % of infected persons.
Hepatitis delta virus diagnostics occur by means of laboratory blood analysis. If infection with hepatitis B and D occurred simultaneously, the symptoms are often absent or typical of hepatitis B. If infection with hepatitis D occurs in addition to the existing chronic hepatitis B (the so-called superinfection, which is rare), the symptoms are very pronounced, and the survival rate in such case is low — 60 %.
How is hepatitis D transmitted?
Up to date, about 15 million of people are infected with this virus. Infection occurs, as in the case of the hepatitis B virus, through blood (transfusion, non-sterile medical or manicure equipment, unprotected sexual intercourse, use of common syringes, during traumatic births from the mother to the child, etc.).
How are hepatitis B and D treated?
Hepatitis B and D treatment is much similar to hepatitis B treatment. Because of the mutually reinforcing action of viruses, a positive treatment result is more difficult to achieve and takes more time. The therapy includes antiviral agents aimed at transferring viruses from the active phase to the resting one, which will allow to avoid the liver cirrhosis development. In the REGENERATION Clinic, standard techniques are supplemented by the latest developments of biotechnologists and the original know-how of the clinic’s doctors. The therapy intensifies the fight of the immune system against viruses and restores damaged liver cells.
of carriers of hepatitis B and D virus combination develop liver cirrhosis
after infection with hepatitis B and D viruses, liver cirrhosis develops
complicated treatment of the combination of hepatitis and faster cirrhosis development
Essence of Treatment
use of antiviral agents.
use of antiviral agents with new developments for support of the immune system stimulation, as well as recovery and protection of liver cells
Life Expectancy of the Patient
10–12 years from the moment of infection.
Life Quality of the Patient
deteriorates every year due to cirrhosis development.
the patient leads active life
Appointment for the consultation by a doctor of the REGENERATION Clinic
The hepatologist will prescribe an examination aimed at confirming or refuting the diagnosis, examining the liver. When establishing the diagnosis, related specialists may be involved
After receiving the analysis results confirming the presence of hepatitis B+D, the patient is prescribed an individual treatment regimen aimed at transferring the virus into the resting phase, treating liver fibrosis/cirrhosis, and supporting the patient’s life quality. If hepatitis B+D is not confirmed, additional tests may be prescribed to identify the cause of the patient’s poor health
The attending physician conducts regular monitoring of the treatment dynamics, and if necessary, adjusts the treatment regimen to achieve a positive result